Advertisement
Advertisement
IPHA
Innate Pharma S.A. ADS
1.81
USDSponsored
-0.08
-4.47%
Jun 25, 09:43 UTC -4
Open
IPHA Earnings Reports
Positive Surprise Ratio
IPHA beat 0 of 2 last estimates.
0%
Next Report
Date of Next Report
Sep 17, 2026
Estimate for Q2 26 (Revenue/ EPS)
$7.97M
/-$0.09
Implied change from Q1 26 (Revenue/ EPS)
+185.62%
/-83.64%
Implied change from Q2 25 (Revenue/ EPS)
--
/--
Innate Pharma S.A. ADS earnings per share and revenue
On Apr 01, 2026, IPHA reported earnings of -0.55 USD per share (EPS) for Q1 26, missing the estimate of -0.16 USD, resulting in a -240.35% surprise. Revenue reached 2.79 million, compared to an expected 2.34 million, with a 19.07% difference. The market reacted with a +5.47% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 2 analysts forecast an EPS of -0.09 USD, with revenue projected to reach 7.97 million USD, implying an decrease of -83.64% EPS, and increase of 185.62% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
What were Innate Pharma S.A. ADS's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Innate Pharma S.A. ADS reported EPS of -$0.55, missing estimates by -240.35%, and revenue of $2.79M, 19.07% above expectations.
How did the market react to Innate Pharma S.A. ADS's Q1 2026 earnings?
The stock price moved up 5.47%, changed from $1.28 before the earnings release to $1.35 the day after.
When is Innate Pharma S.A. ADS expected to report next?
The next earning report is scheduled for Sep 17, 2026.
What are the forecasts for Innate Pharma S.A. ADS's next earnings report?
Based on 2
analysts, Innate Pharma S.A. ADS is expected to report EPS of -$0.09 and revenue of $7.97M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement